Regulation of cell proliferation is a complex process involving coordinate expression of a limited number of genes. In particular, the trigger from the resting state to proliferation requires a rapid transduction of the mitogenic signal through biochemical events involving cascades of gene activations. Previous works have led to the identification of a set of immediate-early RNA species which rapidly and transiently accumulate upon growth stimulation (2, 26, 37, 38) and of some genes specific to growth-arrested cells, whose RNAs are accumulated during serum starvation and rapidly degraded when proliferation resumes (17, 59) . Some encoded products, such as Fos-and Jun-related proteins, turned out to be transcriptional factors whose targets are far from being fully characterized. However, the tumorigenic potential of these switch genes stresses the important function of the target gene products in cell proliferation. Other early-induced genes were shown to code for cytoskeletal and extracellular matrix proteins, transmembrane proteins, and cytokines (reviewed in reference 31). Recently, two mRNAs encoding Ras-related proteins were shown to be mitogen inducible: rhoB, rapidly and transiently induced in growthstimulated rat fibroblasts (33) , and rac2, slowly and stably induced in phytohemagglutinin A-stimulated human peripheral blood lymphocytes (56) .
Proteins that belong to the Ras superfamily share sequence identities with ras proto-oncogene products, especially with GTP-binding and hydrolysis domains, and can be divided into four major groups on the basis of amino acid sequence (10, 11) : (i) products of the ras subgroup, that includes ras proto-oncogenes (H-ras, K-ras, and N-ras) (23, 39) and ral and rap genes (16, 52) , (ii) products of the rab or YPT subgroup (62) , (iii) the rho gene products (41, 53) , and (iv) TC4 (22) . These proteins are ubiquitously expressed in mammals (5, 9, 49) , except Rab-3 (brain specific [49] ) and Rac2 (restricted to the hemopoietic lineage [56] been shown to participate in cell proliferation and differentiation (H-Ras, K-Ras, and N-Ras), vesicular transport (YPT1 [4] and Rab-4 [64] ), cell polarity and cytoskeleton integrity (Cdc42 [35] ), scaffolding of actin microfilaments (RhoA [50] and RhoC [14] ), and in vitro NADPH oxidase activation (Racl [1] ).
We prepared a cDNA library from hamster CCL39 fibroblasts treated for 5 h with serum and isolated a set of late-induced genes, among which an mRNA encoding a new small GTPase was characterized. Phylogenetic analysis including hamster and human sequences indicates that this new GTPase belongs to the rho gene family and suggests that it might have diverged early during evolution. RNA accumulation is in proportion with the strength of the mitogen used, as a result of transcriptional activation. Tissular distribution of the corresponding mRNA is positively correlated with the presence of blood vessels, including smooth muscle cells from which the CCL39 hamster fibroblastic cell line has been derived.
MATERIALS AND METHODS
Cell culture. CCL39 and HeLa cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS) . Confluent cells were made quiescent by serum deprivation in Dulbecco's modified Eagle's medium for 20 h. Renewed growth was stimulated by addition of 10% FCS, ao-thrombin (1 U. ml-'), or fibroblast growth factor (FGF; 35 ng-ml-1) in combination with insulin (10 ,ug* ml-'). Concentrations were 100 nM for tumor promoter agent (TPA) and 1 mM for 8-bromo-cyclic AMP . Protein synthesis and RNA transcription were inhibited by cycloheximide (CHX; 10 jig. ml-') and actinomycin D (ActD; 5 p.g. ml-'), respec- tively.
RNA extraction and analysis. Rodent CCL39 and human HeLa cell RNA was extracted as previously described (26) . Poly(A)+ RNA was purified by oligo(dT)-cellulose (Sigma) chromatography. Total RNA (10 ,ug) was fractionated on 2 M formaldehyde-containing 1% agarose gels, transferred, and bound to nylon membranes (Hybond N+; Amersham) as described by the supplier. Filters were hybridized for 12 to 24 h in a mixture containing 50% formamide, 5 x Denhardt's solution, 10 mM P04 buffer, 0.75 M NaCl, 0.1% sodium dodecyl sulfate (SDS), 10% dextran sulfate, and 100 ,ug of denatured salmon sperm DNA ml-' at 42°C by using 2p_ labeled nick-translated probes (106 cpm/ml). Filters were washed twice in 2x SSC-0.1% SDS (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at room temperature and once in 0.2x SSC-0.1% SDS at 65°C.
Construction of hamster and human cDNA libraries. The cDNA cloning procedure was derived from a primer-adapted method (12a). Poly(A)+ RNA (0.5 ,ug) was primed with 600 ng of oligo(dT) linker, and first-strand synthesis was performed with 200 U of Moloney murine leukemia virus reverse transcriptase (Bethesda Research Laboratories). High-molecular-weight products were recovered after 0.1% cetyltrimethyl ammonium bromide precipitation (6) . RNA was hydrolyzed in 0.3 N NaOH for 30 min at 65°C, and DNA was size fractionated on an S400 filtration column (Pharmacia LKB). Large-size cDNAs (>0.5 kb) were then dG tailed and annealed to dC-tailed, BamHI-cut pT3T718U phagemid DNA (Pharmacia LKB) (cDNA-vector ratio, 40 ,ug of ampicillin ml-' and then frozen in 30% glycerol at -800C.
Differential screening procedure. The library derived from hamster cells was plated at low density (four to five colonies per cm2) on nylon membranes (Hybond N; Amersham) and screened by differential hybridization using a high-specificactivity 32P-labeled cDNA probe (1 x 109 to 2 x 109 dpm p.g-1) prepared from poly(A)+ RNA of quiescent or serum-stimulated cells. Only one round of hybridization was performed, using an activity of 2 x 106 to 3 to 106 dpm. ml-'. Autoradiograms were digitized with an imageprocessing workstation (Visage System; Millipore). BioImage two-dimensional-analysis software was used for spot recognition, signal quantitation, and automatic spot comparison. Differentially expressed clones were then isolated and grown overnight at 37°C. Phagemid DNA was then extracted and used to probe Northern (RNA) analysis membranes.
Run-on analysis. Preparation of nuclei and elongation of nascent transcripts were done as described by Greenberg and Ziff (28) . Dot spotting of DNA onto nitrocellulose and hybridization and washing conditions were as previously described (51) . Before autoradiography, filters were RNase A treated in 2x SSC for 15 min at 25°C.
Screening of HeLa cDNA library. A fraction of the library (40,000 clones) derived from exponentially growing HeLa cells was plated at low density (20 colonies per cm2) on nylon membranes (Hybond N; Amersham) and prehybridized for 10 h in a mixture containing 50% formamide, 5 x SSC, 0.75 M NaCl, 5 x Denhardt's solution, 10 mM phosphate buffer (pH 7.0), 200 ,ug of sonicated denatured salmon sperm DNA ml-1, and 1% SDS. Hybridization was performed in the same buffer with 4, 105 dpm of heat-denatured heterologous hamster 32P-labelled insert ml-1 (6 108 dpm/,ug). Filters were washed twice for 30 min in 2x SSC-0.1% SDS at room temperature and autoradiographied for 5 h. Phagemid DNA was extracted from pools of colonies isolated from the positive areas, restricted with BamHI and HindlIl restriction enzymes, size fractionated on a 1% agarose gel, and transferred onto nylon N+ membranes. Filters were hybridized with the hamster probe under the same conditions as described above, and plasmids exhibiting a positive insert of full-length size copy were chosen. The corresponding cultures were then plated at a lower density, and individual positive clones were selected after a second round of screening.
Sequence determination and characterization of cDNA clones. Individual clones were grown in 2-ml overnight cultures, and plasmid DNA was prepared. Sequence determination was performed on crude double-stranded plasmid DNA by using the T7 sequencing kit (Pharmacia). The complete sequences of PlAl cDNA and its human counterpart were obtained on both strands from subclones that were generated by various internal deletions and from the use of specific primers. Data base searches and sequence analyses were worked out by using CITI2 facilities (19) and homemade softwares.
Phylogenetic analyses. Phylogenetic analyses were performed with the TREEALIGN program for nucleic and protein sequence alignment, distance computation, and construction of phylogenetic trees (30) . The last was also performed by another method based on parsimony and maximum-likelihood procedures (PHYLIP package) (25) .
Nucleotide sequence accession numbers. The EMBL accession numbers for hamster and human rhoG cDNA sequences are X61588 and X61587, respectively. The position of 28S rRNA was determined before transfer by UV shadowing. Sizes of the hybridized transcripts are indicated. For the histograms, cells were serum stimulated for the indicated times (in hours) and RNA was analyzed as described above. Signals corresponding to PlAl, rhoA, racl, and Ha-ras were quantified by using a Biolmage Sun workstation (Millipore), corrected according to P2G4 variations, and plotted as relative mRNA levels. Comparable signals were obtained after an overnight exposure for rhoA and PlAl and 1-week exposure for Ha-ras and racl.
RESULTS

Construction
one. This clone contained a 1.3-kb insert, which was purified and used to probe a Northern blot containing equal amounts of total RNA isolated from CCL39 cells stimulated to grow for various times with FCS. As shown in Fig. 1 , a 1.4-kb RNA species that accumulates transiently, exhibiting a three-to fourfold accumulation 8 to 12 h after FCS addition and then returning to the prestimulation level after 20 h, is revealed. To monitor the FCS effect and RNA amounts, blots were probed with murine c-fos cDNA (65a), and glyceraldehyde-3-phosphate dehydrogenase (66) probes (not shown) and with the insert of the P2G4 clone isolated from the hamster library for its constant level of expression between the resting and proliferative states. Partial DNA sequencing followed by a search in the GenBank and EMBL data bases revealed a significant similarity with various ras-like nucleic sequences belonging to the rho family. To compare the pattern of PlAl mRNA expression with those of other ras-like RNAs, we probed the Northern blots for racl, rac2, rhoA, and Ha-ras. Autoradiograms were quantified with a Visage (Millipore) workstation, and results are plotted in Fig. 1 . rac2 expression was undetectable in our cell system, while Ha-ras and racl RNA (2.4 and 1.1 kb), expressed at very low levels (1 week of exposure time was needed), displayed a twofold induction after 1 to 3 h of FCS treatment. rhoA was expressed as two RNA species that both exhibited a level similar to that of PlAl RNA and were twofold induced within the first hour of stimulation. [16] ).
In the second set, we analyzed 11 protein sequences, including eight human Rho members (RhoA, RhoB, and RhoC [15, 69] ; Racl and Rac2 [20] ; TC10 [22] GCTTCTCGAGCCCGGAGCCGCTGCCGCCGCCCCCAGCTCCCCCGCCTCG*GGAG*GGGCACCAGGTCACTGCAGCCAGAGGGGTC
GGT GAT GGG GCT GTG GGC AAG ACG TGC CTG CTC ATC TGC TAC ACA ACT AAC GCT TTC CCC AAA
CCC ATC ACA CCG CAG CAG GGC CAG GCA CTC GCG AAA CAG ATC CAC GCT GTG CGC TAC CTC GAA
CTGCCC*CTCTGGCTTG*GGAACA*C***TGGGTA*TTCTCATGAGCTCATCCAAGCCAAGGTTGGACCCCTCCCCAAGAGGC
Sequence comparison of human (top line) and hamster (bottom line) rhoG full-length cDNAs and proteins. Sequences were worked out by using the CITI2 facilities (19) . Identical residues are indicated by dashes. Deletions in nucleotide sequences are shown by asterisks.
sequences is shown in Fig. 3A . Multiple sequence alignments were then used to compute identity and distance scores between members of each pair (Table 1) . These statistical properties were processed to trace the evolution of nucleic and protein sequences, presented in Fig. 3B 
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FIG. 3. (A) Sequence comparison of Rho proteins. Protein se-3 RAC1
quences were aligned by using the TREEALIGN software (30 12, 1992 on 32P-labeled nuclear run-on transcripts were hybridized to slot blots of plasmidic DNA containing various inserts. Filters were washed, RNase treated, and autoradiographed for 6 days. Signals were processed by using the Biolmage Whole Band analysis software, and integrated optical densities were plotted as transcriptional activities relative to those of unstimulated cells. exhibit different mitogenic strengths: DNA synthesis is elicited in 10 to 20% of cells treated with FGF, in a slightly higher percentage of cells treated with FCS, and in 50 to 60% of cells treated with ao-thrombin (55) . To ensure that rhoG mRNA accumulation is correlated to the mitogenic response induced by growth factors, we tested the antimitogenic effect of 8-bromo-cAMP on a-thrombin stimulation. As shown in Fig. 4 (right panel) , accumulation of rhoG mRNA is 80% inhibited when 8-bromo-cAMP is added in conjunction with ao-thrombin, which strongly suggests that biochemical pathways involved in DNA synthesis are responsible for the increase in the rhoG RNA level.
Effect of CHX on mRNA accumulation. A common property shared by early growth-regulated mRNAs is their ability to superaccumulate when protein synthesis is inhibited, mainly as a result of mRNA stabilization (2, 60, 67) . We examined the possibility that rhoG mRNA could behave in a similar way by Northern analysis of total RNA extracted from cells treated with combinations of FCS and CHX. As shown in Fig. 5A , a 10-h stimulation with FCS in the presence of CHX led to a 10-fold increase in rhoG mRNA level compared with that in resting cells. Nevertheless, CHX addition also provoked a 2-to 3-h lag period before the start of RNA accumulation (compare with Fig. 1 ). As an internal control, we reprobed the same blot for expression of c-fos, whose mRNA superaccumulated rapidly and then gradually disappeared, in agreement with what was previously reported (26, 55, 67) . When cells were treated with CHX alone, only a slight increase in mRNA level was detected on overexposed films, even after a 6-h incubation (Fig. 5B) , thereby indicating that serum stimulation is necessary for rhoG mRNA superaccumulation. The involvement of early Resting cells were stimulated with FCS and with ca-thrombin. ActD (5 pLg ml-) or ActD plus 10 p,g of CHX ml-) were then added. Total RNA was extracted at various times after cell treatment, transferred to nylon membranes, and probed for rhoG and P2G4 (see text). Results were quantified by using a Visage Sun workstation (Millipore), and integrated optical densities were measured. ND, not determined.
expressed products in superaccumulation was tested by adding CHX 1 or 2 h after serum stimulation and then pursuing the incubation for 5 or 4 h, respectively (Fig. 5B , lanes 6A and 6B). Interestingly, the rhoG RNA level was increased when addition of CHX was delayed for 2 h rather than 1 h. This result is consistent with the lagging effect of CHX (see above) and suggests that protein synthesis, although not necessary, has a positive effect on rhoG gene activation during the first 2 h of serum stimulation. Regulation of rhoG mRNA expression. In order to determine the mechanisms involved in rhoG mRNA accumulation, transcriptional activity of the rhoG gene was analyzed by run-on experiments on nuclei isolated from cells treated for various times with FCS. In vitro 32P-labeled elongated RNA was hybridized to plasmidic DNA immobilized on nitrocellulose membranes, and signals were quantified by image analysis. As shown in Fig. 6 , FCS addition elicits a transient increase in the transcriptional activity of rhoG, which exhibits a threefold induction after 4 h and then progressively returns to its unstimulated level after 24 h. This induction takes place 2 to 3 h before the increase in cytoplasmic RNA and can account for the range of mRNA accumulation (Fig. 1) . Three other probes (isolated during the same screening procedure as rhoG and corresponding to thrombospondin, a-tubulin, and -y-actin) were also included in the experiment to monitor the extent of the stimulation (Fig. 6) . No transcriptional activation is observed for the y-actin gene, while thrombospondin and a-tubulin display, respectively, eight-and threefold induction 2 h after serum addition, in agreement with published data (46, 48) .
We then tested the effect of CHX treatment on rhoG mRNA stability and gene transcription by ActD chase experiments and run-on analysis. Resting cells and cells stimulated with FCS or thrombin for 6 and 12 h were treated with combinations of ActD and CHX, and the level of rhoG mRNA at various times was estimated by Northern blotting experiments. Autoradiograms were quantitated, and results are presented in Table 2 . rhoG mRNA exhibits a higher turnover rate in cells stimulated with FCS or thrombin for 12 h (half-life [t1l2] = 2.3-2.6 h) and 6 h (t412 = 2.9 h) than in resting cells (t1l2 = 3.5 h), and a combined treatment with CHX and ActD leads to a fourfold increase in mRNA stability in both the resting and stimulated states. rhoG transcriptional activity was measured by run-on analysis of cells treated with CHX alone or in combination with serum. The results presented in Fig. 6 led to several observations. First, transcription is slightly activated by FCS in the presence of CHX during the first 6 h, but it is not comparable to the superinduction observed for c-fos (26) or thrombospondin genes. Second, an increase in transcription occurs later when FCS is added in combination with CHX, which is in agreement with the delayed accumulation of cytoplasmic RNA (Fig. 5A ). These data therefore establish that rhoG transcriptional activation does not strictly require de novo protein synthesis and that RNA superaccumulation in the presence of CHX results from a stabilizing effect, as is the case for numerous primary response RNAs.
rhoG mRNA expression in various human organs. Expression of several GTPases has been shown to be tissue specific (20, 22, 49) . To determine whether rhoG mRNA is expressed in particular cell types, we probed a Northern membrane containing poly(A)+ RNA isolated from various human organs (Multiple Tissue Northern; Clontech). A single rhoG 1.4-kb mRNA species is present in RNAs from all organs but displays pronounced quantitative variations (Fig. 7) : strong expression was found in placental and lung tissues and to a lesser extent in the heart. The other five organs displayed weaker expression in the following decreasing order: kidney, brain, skeletal muscle, liver, and pancreas. These variations do not reflect differences in amounts of loaded RNA, as a different pattern was obtained for glyceraldehyde-3-phosphate dehydrogenase mRNA, whose expression is particularly high in skeletal and cardiac muscles. (10, 11) . All of these features were also found in the protein sequence derived from the human homolog cDNA clone. Sequence comparison of hamster and human sequences with known Ras-like proteins revealed that this GTPase is a new member of the Rho family (referred to as RhoG). Although it shares substantial amino acid identity with Racl and Rac2, phylogenetic analysis strongly suggests that it is topologically distinct from Rac and has probably diverged first from the common stem shared by Rac, TC10, and CDC42.
Two ras-like genes, rhoB (33) and rac2 (56), have been recently described as growth-regulated genes: rac2, which is the closest relative of rhoG, is specifically expressed in cells of the hemopoietic lineage and is strongly induced within 6 h in peripheral blood lymphocytes stimulated with phytohemagglutinin A and in T cells stimulated to grow. rhoB, which belongs to the sister subgroup of rhoG within the rho gene family and is an immediate-early response to epidermal growth factor, platelet-derived growth factor, and FCS and to the oncogenic v-Fps protein tyrosine kinase activation. Interestingly, this gene is not induced upon PKC activation or by signals transduced through other protein tyrosine kinases, such as insulin or FGF. We describe here a third case of a growth-regulated rho gene, rhoG, which belongs to the group of late primary response genes: its RNA accumulates gradually for 8 to 10 h after serum addition, as a result of transient transcriptional activation. Because of its moderate instability, rhoG cytoplasmic RNA then returns progressively to its prestimulation level 10 to 14 h later. CHX treatment induces a lag period before RNA transcription activation and elicits a superaccumulation due to an increase in RNA t1l2. However, the latter property, shared by many mRNAs involved in early response to growth factors (2) and by tubulin and histone mRNAs (reviewed in reference 12), is not specific enough to provide information on the nature and the location of the sequence(s) involved in rhoG mRNA degradation. In our cell system, rhoG displays some similarities to Ha-ras, as both genes are induced several hours after serum addition (40) . However, if their regulations share qualitative properties, they differ quantitatively, as rhoG expression is at least 10 times higher than that of Ha-ras. Other rho genes, such as rhoA and rhoC, were previously shown to be uninducible in rat-2 and NRK cells (33) . Our results show that rac2, the closest relative to rhoG, is not expressed in resting or stimulated CCL39 cells, while rhoA and racl are moderately induced but exhibit a pattern of induction distinct from that of rhoG.
An interesting correlation is observed between rhoG mRNA accumulation and the mitogenic strength of the purified factor used for the stimulation: ox-thrombin, which is the most potent mitogenic factor in CCL39 cells (55, 65) , elicits an increase in the rhoG mRNA level much more important than that elicited by FGF alone or in combination with insulin. In addition, a poor induction is observed after TPA treatment, which activates PKC without any mitogenic effect in CCL39 cells. The correlation is further strengthened by the absence of a response to a-thrombin when the transduction pathway is inhibited by an increase in cAMP level (43, 45) . Differences in the rhoG mRNA level in response to various growth factors may rely on the type of receptor and ligand involved in the stimulation and on the cell type on which the receptor is expressed. ao-Thrombin acts through receptors that are coupled through GTP-binding proteins to various effectors, including a phosphoinositide-specific (PIP2) phospholipase C (7, 54) . FGF mitogenic signal is transduced through receptors with tyrosine kinase activity (68) but does not involve PIP2 breakdown and PKC activation in CCL39 cells, and elevation in the cAMP level inhibits PIP2 breakdown (45) . Thus, rhoG induction by mitogens appears to be independent of PKC activation but rather correlates with PIP2 metabolism and more precisely with inositol-1,4,5-triphosphate accumulation. However, as PIP2 phospholipase C is only one of the effectors activated by ax-thrombin, additional data are necessary to determine whether inositol-1,4,5-triphosphate production is sufficient to promote rhoG gene activation in this cell system.
What could be the physiological meaning of rhoG induction? Numerous primary-response genes have already been characterized, isolated from a wide range of cell systems (e.g., murine NIH 3T3, BALB/c, and Swiss 3T3 cells; BHK and hamster lung CCL39 cells; and rat PC12 nerve cells) (2, 18, 32, 48) subjected to different external stimuli (e.g., platelet-derived growth factor, epidermal growth factor, FCS, TPA, and nerve growth factor). Some of them appear to be ligand or cell specific, for instance, cytokines JE and KC, which are preferentially induced by platelet-derived growth factor (18) , and thrombospondin, an extracellular matrix protein whose expression is restricted to cell types such as vascular cells or neurons (reviewed in reference 27). But the majority of them were found to be activated in a variety of cellular contexts, suggesting that cell and ligand specificities rely on changes in the relative amounts of multiple products rather than synthesis of specific ones (31) . RhoG is likely to represent a cell-specific induced response for several reasons. First, its mRNA is expressed at different levels in various cell systems (strong expression in stimulated CCL39 cells and much lower expression in HeLa and LTk-cells [not shown]). Second, tissue distribution of rhoG mRNA reveals a high level of expression in lung, placenta, and to a lesser extent, heart tissue, all of them involving a high proportion of vascular cells. Interestingly, CCL39 cells, which were derived from smooth muscle cells, exhibit a high level of rhoG mRNA in response to ot-thrombin, a hormone directly involved in angiogenesis and wound healing. One can therefore speculate that this new GTPase is specific for vascular cells and participates in their proliferation by acting either directly on the pathway specifying DNA synthesis or indirectly during the setup of specialized functions.
Both possibilities are consistent with what is known about this class of small GTPases. First, various reports have demonstrated their implication in the regulation of cell proliferation: (i) amplification of normal rhoA results in colonies that exhibit reduced dependence on serum for growth and that are tumorigenic in nude mice (3), (ii) the translocation breakpoint in Philadelphia chromosome-positive chronic myeloid leukemias prevents the expression of bcr, which encodes a GAP protein which down-regulates the active GTP-bound form of p2lracI (21) , and (iii) the protooncogene dbl encodes a protein that promotes the catalysis of guanine nucleotide exchange on p21CDC42Hs (29) . In addition, rhoB was found to be an immediate-early gene inducible by various growth factors (33), while the rac2 mRNA level is strongly increased in activated T cells (56) . Second, these proteins are likely to be involved in cytoskeleton organization: (i) microinjection of recombinant p2lrho induces rapid changes in cell morphology (50) , (ii) mutations in the yeast CDC42 gene affect cell polarity, either preventing the correct location of buds on the mother cell or impeding the budding process (34) , and (iii) ADP ribosylation of RhoC in Vero cells results in the disappearance of microfilaments (14) . All of these features suggest that rho proteins are implicated in the modifications of the overall cell structure required for progressing towards the S phase, perhaps by the docking of proteins involved in cytoskeletal reorganization or of extracellular matrix proteins controlling cell adhesion. Along this line, rhoG, which is closely related to rac and CDC42, could be under the control of the same regulatory proteins and implicated in similar pathways.
In conclusion, a new RNA sequence encoding a G protein was found to be induced during the late G1 phase of renewed fibroblastic growth. According to our observations, two non-mutually-exclusive hypotheses can be formulated: (i) RhoG 
